{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:05:38Z","timestamp":1791867938896,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008307","name":"Promedica Stiftung","doi-asserted-by":"publisher","award":["1412\/M"],"award-info":[{"award-number":["1412\/M"]}],"id":[{"id":"10.13039\/501100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009396","name":"Universit\u00e4tsspital Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007404","name":"Clinical Trial Center, China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007404","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-4243-08-2017"],"award-info":[{"award-number":["KFS-4243-08-2017"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ccell.2020.12.022","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T10:30:37Z","timestamp":1611225037000},"page":"394-406.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-8608","authenticated-orcid":false,"given":"Egle","family":"Ramelyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-5610","authenticated-orcid":false,"given":"Aizhan","family":"Tastanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Bal\u00e1zs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desislava","family":"Ignatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-8264","authenticated-orcid":false,"given":"Patrick","family":"Turko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Beisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4808-1845","authenticated-orcid":false,"given":"Michael","family":"Krauthammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell Paul","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2020.12.022_bib1","author":"10x Genomics"},{"key":"10.1016\/j.ccell.2020.12.022_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/2326-6066.CIR-17-0049","article-title":"Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity","volume":"5","author":"Ager","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib3","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib4","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-016-5286-0","article-title":"Patterns of clinical response with talimogene laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM phase III clinical trial","volume":"23","author":"Andtbacka","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib70","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1167\/iovs.08-1807","article-title":"HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium","volume":"49","author":"Akhtar","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ccell.2020.12.022_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-019-0623-z","article-title":"Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma","volume":"7","author":"Andtbacka","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2020.12.022_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2020.12.022_bib8","doi-asserted-by":"crossref","first-page":"D1057","DOI":"10.1093\/nar\/gkz874","article-title":"VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium","volume":"48","author":"Bagaev","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib9","doi-asserted-by":"crossref","first-page":"1591875","DOI":"10.1080\/2162402X.2019.1591875","article-title":"Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma","volume":"8","author":"Bommareddy","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ccell.2020.12.022_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2020.12.022_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.184.2.695","article-title":"CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha","volume":"184","author":"Caux","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2020.12.022_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","article-title":"Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review","volume":"83","author":"Chen","year":"2017","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.ccell.2020.12.022_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.0408197102","article-title":"Regulatory T\u00a0cells suppress tumor-specific CD8 T\u00a0cell cytotoxicity through TGF-beta signals in\u00a0vivo","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.12.022_bib14","first-page":"279","article-title":"Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation","volume":"5","author":"Chistiakov","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ccell.2020.12.022_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11523-020-00712-2","article-title":"Natural killer cells as a potential biomarker for predicting immunotherapy efficacy in patients with non-small cell lung cancer","volume":"15","author":"Cho","year":"2020","journal-title":"Target. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2020.12.022_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"de Simone","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2020.12.022_bib18","doi-asserted-by":"crossref","first-page":"viii146","DOI":"10.1093\/annonc\/mdy279.433","volume":"29","author":"Diab","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2020.12.022_bib20","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2020.12.022_bib21","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","article-title":"The reactome pathway knowledgebase","volume":"44","author":"Fabregat","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/35087061","article-title":"Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1","volume":"3","author":"Farassati","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2020.12.022_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2020.12.022_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2020.12.022_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjd.17240","article-title":"British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018","volume":"180","author":"Gilson","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ccell.2020.12.022_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2016.06.013","article-title":"Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T\u00a0cells","volume":"177","author":"Goding","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib27","doi-asserted-by":"crossref","first-page":"viii443","DOI":"10.1093\/annonc\/mdy289.002","article-title":"Talimogene laherparepvec (T-VEC) treatment increases intratumoral effector T-cell and natural killer (NK) cell density in noninjected tumors in patients (pts) with stage IIIB-IVM1c melanoma: evidence for systemic effects in a phase II, single-arm study","volume":"29","author":"Gogas","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2567.2011.03409.x","article-title":"Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells","volume":"133","author":"Hamann","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.ccell.2020.12.022_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13550280390218788","article-title":"The herpes simplex virus (HSV) protein ICP34.5 is a virion component that forms a DNA-binding complex with proliferating cell nuclear antigen and HSV replication proteins","volume":"9","author":"Harland","year":"2003","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.ccell.2020.12.022_bib30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-11-4558","article-title":"Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in\u00a0vivo and targets interferon-resistant tumor cells","volume":"106","author":"Heinzerling","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.12.022_bib31","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1128\/JVI.73.10.8245-8255.1999","article-title":"Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0","volume":"73","author":"Hobbs","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ccell.2020.12.022_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.192.6.823","article-title":"Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells","volume":"192","author":"Hochrein","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2020.12.022_bib33","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1158\/1078-0432.CCR-06-0759","article-title":"A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor","volume":"12","author":"Hu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1245\/s10434-009-0809-6","article-title":"Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma","volume":"17","author":"Kaufman","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2051-1426-2-11","article-title":"Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma","volume":"2","author":"Kaufman","year":"2014","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2020.12.022_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/2159-8290.CD-RW2020-018","article-title":"Talimogene laherparepvec plus pembrolizumab is effective in sarcomas","volume":"10","author":"Kelly Ciara","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2020.12.022_bib37","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1128\/jvi.65.12.6749-6760.1991","article-title":"Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template","volume":"65","author":"Kibler","year":"1991","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ccell.2020.12.022_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-15-2667","article-title":"Molecular pathways: mechanism of action for talimogene laherparepvec, a new oncolytic virus immunotherapy","volume":"22","author":"Kohlhapp","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.78.5.2530-2536.2004","article-title":"In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.","volume":"78","author":"Linehan","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.ccell.2020.12.022_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301885","article-title":"ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties","volume":"10","author":"Liu","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ccell.2020.12.022_bib40","doi-asserted-by":"crossref","first-page":"9456","DOI":"10.1128\/JVI.73.11.9456-9467.1999","article-title":"Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle","volume":"73","author":"Lomonte","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ccell.2020.12.022_bib41","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3324\/haematol.2013.094243","article-title":"BLUEPRINT: mapping human blood cell epigenomes","volume":"98","author":"Martens","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2020.12.022_bib42","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gkp1019","article-title":"PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium","volume":"38","author":"Mi","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13567-017-0423-8","article-title":"Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines","volume":"48","author":"Mucksova","year":"2017","journal-title":"Vet. Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib44","doi-asserted-by":"crossref","first-page":"eaaz2738","DOI":"10.1126\/sciimmunol.aaz2738","article-title":"NK cells mediate clearance of CD8(+) T\u00a0cell-resistant tumors in response to STING agonists","volume":"5","author":"Nicolai","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","article-title":"IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage","volume":"114","author":"O\u2019garra","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2020.12.022_bib46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T\u00a0cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T\u00a0cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib47","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2020.12.022_bib48","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.4049\/jimmunol.181.9.5912","article-title":"Fas expression on antigen-specific T\u00a0cells has costimulatory, helper, and down-regulatory functions in\u00a0vivo for cytotoxic T\u00a0cell responses but not for T\u00a0cell-dependent B cell responses","volume":"181","author":"Puliaeva","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib49","series-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"key":"10.1016\/j.ccell.2020.12.022_bib50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/imt-2019-0033","article-title":"Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety","volume":"11","author":"Raman","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ccell.2020.12.022_bib51","author":"Reuters"},{"key":"10.1016\/j.ccell.2020.12.022_bib52","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic virotherapy promotes intratumoral T\u00a0cell infiltration and improves anti-PD-1 immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2020.12.022_bib53","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/2159-8290.CD-18-0280","article-title":"SD-101 in combination with pembrolizumab in advanced melanoma: results of a phase ib, multicenter study","volume":"8","author":"Ribas","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2020.12.022_bib54","first-page":"3","article-title":"Human herpersviruses I: a model for molecular organization and regulation of herpesviruses\u2014a review","author":"Roizman","year":"1975","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.ccell.2020.12.022_bib55","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2020.12.022_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41416-019-0574-7","article-title":"The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer","volume":"121","author":"Schreiber","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2020.12.022_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib58","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2020.12.022_bib59","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2020.12.022_bib60","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.12.022_bib61","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The gene ontology resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib62","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jdcr.2019.06.034","article-title":"Talimogene laherparepvec induces durable response of regionally advanced Merkel cell carcinoma in 4 consecutive patients","volume":"5","author":"Westbrook","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.ccell.2020.12.022_bib63","first-page":"971","article-title":"Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus","volume":"34","author":"Wilden","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccell.2020.12.022_bib64","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.12.022_bib65","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","article-title":"Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis","volume":"76","author":"Xia","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib66","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/eji.201141540","article-title":"GM-CSF increases cross-presentation and CD103 expression by mouse CD8(+) spleen dendritic cells","volume":"41","author":"Zhan","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2020.12.022_bib67","first-page":"1382","article-title":"Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ccell.2020.12.022_bib68","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2020.12.022_bib69","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1128\/JVI.76.12.5893-5904.2002","article-title":"Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme","volume":"76","author":"Zhou","year":"2002","journal-title":"J.\u00a0Virol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082030670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082030670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:06:55Z","timestamp":1761523615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153561082030670X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S153561082030670X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2020.12.022","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2020.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}